← GoodRx Holdings, Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | $26.1m | $968.7m | $941.1m | $757.2m | $672.3m | $448.3m | $261.8m | |
| Accounts receivable, net | $48.1m | $68.7m | $118.1m | $117.1m | $143.6m | $145.9m | $235.7m | |
| Prepaid expenses and other current assets | $12.4m | $46.0m | $29.6m | $45.4m | $56.9m | $65.0m | $47.2m | |
| Total current assets | $86.6m | $1.1b | $1.1b | $919.7m | $872.8m | $659.3m | $643.1m | |
| Property and equipment, net | $1.9m | $23.1m | $21.6m | $19.8m | $15.9m | $12.7m | $12.3m | |
| Capitalized software, net | $5.2m | $19.8m | $45.0m | $70.1m | $95.4m | $124.8m | $139.3m | |
| Goodwill | $236.2m | $261.1m | $329.7m | $412.1m | $410.8m | $410.8m | $430.3m | |
| Intangible assets, net | $21.3m | $36.9m | $88.8m | $119.9m | $60.9m | $52.1m | $64.1m | |
| Operating lease right-of-use assets, net | $32.3m | $27.7m | $27.7m | $35.9m | $29.9m | $27.8m | $28.8m | |
| Other assets | $1.2m | $2.0m | $6.0m | $27.2m | $37.8m | $23.5m | $29.1m | |
| Prescription reimbursement assets | — | — | — | — | — | $22.9m | $98.3m | |
| Deferred tax assets, net | $2.2m | $13.1m | $0 | $0 | $65.3m | $77.2m | $57.1m | |
| Prescription reimbursement liabilities | — | — | — | — | — | $15.8m | $130.1m | |
| Accrued expenses and other current liabilities | $15.6m | $37.7m | $50.7m | $47.5m | $71.3m | $99.1m | $86.7m | |
| Operating lease liabilities, current | $2.9m | $4.5m | $5.9m | $4.1m | $6.2m | $5.6m | $4.8m | |
| Debt, net | $663.9m | $659.9m | $655.9m | $651.8m | $647.7m | $486.7m | $483.3m | |
| Operating lease liabilities, net of current portion | $37.1m | $33.5m | $33.6m | $54.1m | $48.4m | $46.0m | $49.8m | |
| Other liabilities | $3.0m | $5.8m | $5.1m | $7.6m | $8.2m | $6.8m | $8.7m | |
| Total assets | $386.8m | $1.5b | $1.6b | $1.6b | $1.6b | $1.4b | $1.4b | |
| Total liabilities and stockholders' equity | $386.8m | $1.5b | $1.6b | $1.6b | $1.6b | $1.4b | $1.4b | |
| Accounts payable | $7.9m | $10.3m | $17.5m | $17.7m | $36.3m | $14.1m | $19.4m | |
| Current portion of debt | $7.0m | $7.0m | $7.0m | $7.0m | $8.8m | $5.0m | $5.0m | |
| Total current liabilities | $33.4m | $59.6m | $81.1m | $76.3m | $122.6m | $123.9m | $246.0m | |
| Total liabilities | $737.4m | $758.8m | $775.9m | $789.8m | $826.8m | $663.4m | $787.8m | |
| Preferred stock, $0.0001 par value; 50,000 shares authorized and nil shares issued and outstanding at December 31, 2025 and December 31, 2024 | — | 0 | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.0001 par value; Class A: 2,000,000 shares authorized, 107,088 and 105,946 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively; and Class B: 1,000,000 shares authorized, 233,964 and 276,869 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 460k | 39k | 40k | 40k | 40k | 38k | 34k | |
| Additional paid-in capital | $8.8m | $2.1b | $2.2b | $2.3b | $2.2b | $2.2b | $2.0b | |
| Accumulated deficit | ($1.1b) | ($1.4b) | ($1.4b) | ($1.4b) | ($1.5b) | ($1.4b) | ($1.4b) | |
| Total stockholders' equity | ($1.1b) | $711.4m | $831.7m | $814.8m | $762.0m | $724.7m | $616.3m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.